High levels of prolactin (PRL) are associated with inhibition of lutelnizing hormone secretion in several mammalian species. We asked whether this phenomenon could be explained by a direct inhibitory action of PRL on hypothalamic gonadotropin hormone-releasing hormone (GnRH) neurons. The ability of PRL to suppress GnRH release and expression was tested in the highly differentiated GT1 GnRH cell lines. In static culture, nmomolar concentrations of either rat or mouse PRL inhibited the release of GnRH in a dosedependent fashion. PRL treatment for 24 hr also decreased GnRH mRNA levels determined by Northern analysis. The cells were shown to express the PRL receptor gene, and the mRNAs for both the short and long forms were present by Northern and PCR analysis, although the short form was more abundant. In Western blots with monoclonal antibody against the rat liver PRL receptor, the short 42-kDa form of the receptor was observed. These results demonstrate that PRL inhibits GnRH release and possibly gene expression in GnRH neurons. This action appears to be mediated through prolactin receptors expressed by the cells.
During normal physiological states associated with elevated prolactin (PRL), luteinizing hormone (LH) levels are lowered-e.g., during pregnancy, pseudopregnancy, postpartum, and lactation (1, 2) . In women elevated PRL levels resulting from an anterior pituitary tumor or the therapeutic use of dopamine antagonists result in amenorrhea (1, 2) . Hyperprolactinemia inhibits the postcastrational rise in LH levels in a dose-dependent fashion in male rats (3) . One hypothesis to explain these findings is that elevated PRL levels act centrally to inhibit gonadotropin hormonereleasing hormone (GnRH) release, which in turn results in lowered LH levels.
We used GT1 GnRH neuronal cell lines to test the hypothesis that PRL acts directly on GnRH neurons to modulate GnRH release. The GT1 cell lines were isolated from a GnRH-secreting tumor induced in a transgenic mouse by genetically targeted tumorigenesis (4) . GT1 cells appear to be highly differentiated neurosecretory neurons. They have a neuronal phenotype, express neuronal but not glial markers, and have functional fast, tetrodotoxin-sensitive sodium channels (4) (5) (6) . In addition, they express and process the GnRH gene (6) and release GnRH in response to depolarization (4) . Basal release of GnRH from GT1 cells is pulsatile, with a pulse frequency identical to that seen in the mouse (7) (8) (9) . The cells also have cilia, which is a unique characteristic of hypothalamic GnRH neurons (10) .
We demonstrate that PRL at physiological concentrations inhibits GnRH release and mRNA levels. Consistent with this observation, the cells express PRL receptors as shown by Northern, PCR, and Western analysis. RNA Extraction. Total RNA was extracted from cells cultured on 100-mm dishes using the procedure of Chomczynski and Sacchi (12) . Briefly, cells were lysed in guanidinium solution (4 M guanidinium thiocyanate/25 mM sodium citrate, pH 7/0.5% sarcosyl/0.1 M 2-mercaptoethanol), the lysate was phenol/chlorophorm extracted, and RNA was precipitated in ethanol. Total tissue RNA was extracted by the urea/lithium chloride method (13) . All RNAs were dissolved in diethyl pyrocarbonate-treated water and the integrity ofRNA was checked on agarose gels. Poly(A)+ RNA was purified directly from cell lysates using oligo(dT) affinity resin (14 (15) . The probe for cyclophilin was a 700-bp-long BamHI insert ofplasmid plB15 (16) . The PRL receptor probe was a 1.6-kb EcoRI insert ofthe Abbreviations: GnRH, gonadotropin hormone-releasing hormone; PRL, prolactin; LH, luteinizing hormone.
MATERIALS AND METHODS
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. The amplification conditions were as follows: denaturation at 94°C for 1 min, annealing at 65°C for 2 min, and extension at 72°C for 2 min. After amplification the samples were separated on a 3% agarose gel stained with ethidium bromide. Two different amplification reactions were carried out. In both of them the forward primer was 5'-CATGGATACTG-GAGTAGATGGAGC-3' (A). Reverse primers were 5'-CC-CTTCAAAGCCACTGCCCAGAC-3' (B), common for both forms of the receptor, and 5'-CTCAGCAGCTCTTCA-GACTTG-3' (C), specific for the long form of the receptor. Location of the primers is shown in Fig. 4 . A negative control was included in each amplification reaction to control for possible cross-contamination.
Membrane Preparation. Cells grown on 100-mm dishes (1.5-2 X 107 cells) were washed twice with phosphatebuffered saline, then scraped and resuspended in 25 mM Tris HCl, pH 7.6/10 ,uM leupeptin/1 mM phenylmethylsulfonyl fluoride, and lysed in Eppendorf tubes by three freeze/ thaw cycles. The lysed cells were microcentrifuged for 10 min, and the pellet was resuspended in 25 mM Tris HCl, pH 7.5/10 mM MgCl2/10 AM leupeptin/1 mM phenylmethylsulfonyl fluoride (19) . Microsomal membrane fractions from rat and mouse liver were prepared as described (20) . Protein concentration was measured by the Bradford method using bovine serum albumin as the standard (21) .
Western Analysis. Twenty-five micrograms of the microsome fraction was boiled for 4 min under reducing conditions in 50 mM Tris HCl (pH 6.8) containing 10% glycerol and 2% SDS and subjected to SDS/polyacrylamide gel electrophoresis (22) . Proteins were electrophoretically transferred onto poly(vinylidene difluoride) membranes (Immobilon-P transfer membrane, Millipore) at 40 V, at 4°C overnight. After saturation of nonspecific protein binding sites with 3% bovine serum albumin/0.1% Nonidet P-40 for 2 hr, blots were incubated with the anti-PRL receptor monoclonal antibodies [U5 or U6 (23); dilution, 1:1000]. The bands were revealed by the horseradish peroxidase-coupled anti-mouse antiserum (dilution, 1:4000) and enhanced chemiluminescence Western blotting kit (ECL Western blotting, Amersham).
Data Analysis. Data were analyzed by analysis of variance followed by Student t test.
RESULTS
Incubation of GT1 cells with PRL induced a significant inhibition of GnRH release into the medium. As shown in Fig.  1 , either mouse PRL (Fig. la) or rat PRL (Fig. lb) growth hormone (10 pM-10 nM) in similar experiments had no effect on the secretion of GnRH (data not shown).
Levels of GnRH mRNA transcripts were measured by Northern analysis in cells incubated in PRL for various times. The GnRH probe hybridized to a single band of 510 bp, whereas the cyclophilin probe hybridized to a 900-bp band. We did not observe any change in the level of GnRH mRNA after 1, 2, 3, 4, or 6 hr of incubation with PRL (data not shown). However, prolonged incubation for 24 hr resulted in a decrease in the level of GnRH mRNA, as seen by Northern analysis (Fig. 2a) . In experiments in which mRNA levels were measured by dot blots, a 40%o decrease (P < 0.05) was observed with 10 nM PRL (Fig. 2b) .
Hybridization of poly(A)+ RNA (30 Mg) from GT1-7 cells
with the F3 PRL receptor probe, which recognizes short and long forms of the receptor, detected a band at 2.1 kb, similar to that observed for pregnant rat liver RNA (1.8 kb, Fig. 3a) .
PCR analysis of reversed transcribed mRNA from GT1-7 cells yielded fragments of 150 bp using primers A and B and 250 bp using primers A and C (Fig. 4) liver preparations. Several larger bands were observed with GT1-7 membranes, one of which was 80 kDa. As a control, incubation with monoclonal antibody (U6), which crossreacts with mouse liver PRL receptor with very low affminty, did not stain any band in blots of GT1-7 cell membranes.
DISCUSSION
All of our data support the hypothesis that the reciprocal relationship between LH and PRL levels is mediated through Consistent with PRL directly affecting GnRH release and mRNA levels, PRL receptors are expressed on GT1 cells. The mRNA for the short form of the receptor was detected by Northern and PCR analysis, whereas that for the long form was only observed by PCR analysis. The short and possibly long forms ofthe receptor could also be observed by Western analysis using an antibody that recognizes both forms of the receptor. These findings are consistent with the short form of the receptor being expressed at higher levels. In agreement with these observations, PRL receptors (27, 28) and appropriate mRNAs (29) were shown to be present in the brain. Recently, by PCR analysis, the short and long forms of the PRL receptor were identified in the anterior hypothalamus of the rat, the region in which GnRH cell bodies are located (29) . However, it was not possible to determine which cell type expressed the receptor.
The two forms of the PRL receptor, short (17) and long (30) , differ in the sequence and length of their cytoplasmic domain. Transcripts coding these two forms are the result of alternative splicing of a common primary transcript (24) . The expression of the two forms is tissue specific, with the short form being predominant in the liver and the long form being most abundant in the ovary (30) . In the mouse, seven transcripts encoding at least two forms of the PRL receptor with tissue-specific expression and regulation were recently described (31) . Potentially the two forms of the PRL receptor mediate different actions of PRL. In Chinese hamster ovary cells transfected with a reporter gene whose expression is induced by PRL, expression ofthe long but not the short form of the receptor was capable of transactivating the action of PRL (32) . The role of the short form is unknown, although in the liver and in the mammary gland it is the predominant form of the receptor (25) . Which form of the receptor is mediating the action of PRL in GT1 cells is not clear at this time. This question is addressable by stably transfecting the GT1 cells with various forms of the PRL receptor and observing the effects on GnRH secretion and mRNA levels.
In conclusion, we have shown that the GT1 GnRH neuronal cell lines respond to the inhibitory action of PRL. By multiple criteria the cells express PRL receptors that have been shown to mediate the action of PRL in other tissues. These observations could help to explain the consistent observation in mammals that high levels of PRL result in the inhibition of reproductive function. Whether PRL secreted from the anterior pituitary or produced in neurons in the brain (33) (34) (35) is responsible for the effect on GnRH remains to be elucidated. Effects on GnRH neurons do not eliminate the possibility that PRL could act at additional sites in the brain to inhibit the release of GnRH, possibly through an action on GABAergic (GABA, y-aminobutyric acid) neurons (36) .
